Dawson, R.Mcleod, D.Koerber, J.Plummer, J.Dracopoulos, G.2018-09-102018-09-102016Anaesthesia, 2016; 71(3):285-2900003-24091365-2044http://hdl.handle.net/2440/114312We used 20 ml ropivacaine 0.75% for ankle blocks before foot surgery in 90 participants who we allocated in equal numbers to: perineural dexamethasone 8 mg and intravenous saline 0.9%; perineural saline 0.9% and intravenous dexamethasone 8 mg; or perineural and intravenous saline 0.9%. Dexamethasone increased the median (IQR [range]) time for the return of some sensation or movement, from 14.6 (10.8-18.8 [5.5-38.0]) h with saline to 24.1 (19.3-29.3 [5.0-44.0]) h when given perineurally, p = 0.00098, and to 20.9 (18.3-27.8 [8.8-31.3]) h when given intravenously, p = 0.0067. Dexamethasone increased the median (IQR [range]) time for the return of normal neurology, from 17.6 (14.0-21.0 [9.5-40.5]) h with saline to 27.5 (22.0-36.3 [7.0-53.0]) h when given perineurally, p = 0.00016, and to 24.0 (20.5-32.3 [13.0-42.5]) h when given intravenously, p = 0.0022. Dexamethasone did not affect the rates of block success, postoperative pain scores, analgesic use, or nausea and vomiting. The route of dexamethasone administration did not alter its effects.en© 2015 The Association of Anaesthetists of Great Britain and IrelandFootHumansPain, PostoperativeSodium ChlorideAmidesDexamethasoneAnesthetics, LocalGlucocorticoidsAnesthesia Recovery PeriodTime FactorsAdultAgedAged, 80 and overMiddle AgedFemaleMaleRopivacaineA randomised controlled trial of perineural vs intravenous dexamethasone for foot surgeryJournal article003004228310.1111/anae.133460003701614000072-s2.0-849592224892-s2.0-84951757095226721